4.8 Article

Multifunctional nanolocks with GSH as the key for synergistic ferroptosis and anti-chemotherapeutic resistance

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

Mitochondrial Ca2+-overloading by oxygen/glutathione depletion-boosted photodynamic therapy based on a CaCO3 nanoplatform for tumor synergistic therapy

Jiawei Zhu et al.

Summary: A CaCO3-based nano-platform responsive to the tumor microenvironment was designed. The released CAT and BSO relieved tumor hypoxia, enhanced PDT efficacy, and induced cell apoptosis, while also destroying the Ca2+ buffering capacity leading to mitochondrial Ca2+ overloading. The synergistic effect of enhanced PDT and mitochondrial Ca2+ overloading showed remarkable antitumor performance.

ACTA BIOMATERIALIA (2022)

Article Oncology

Immunometabolic Interplay in the Tumor Microenvironment

Irem Kaymak et al.

Summary: The study discusses the metabolic characteristics of immune cells in the tumor microenvironment and proposes future research directions.

CANCER CELL (2021)

Article Oncology

Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer

Ali Ghoochani et al.

Summary: The study found that mediators of ferroptosis are expressed in treatment-resistant prostate cancer, and treatment with ferroptosis inducers such as erastin and RSL3 can significantly reduce prostate cancer cell growth and migration, potentially serving as novel therapeutic strategies.

CANCER RESEARCH (2021)

Article Multidisciplinary Sciences

mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation

Yilei Zhang et al.

Summary: Cystine uptake promotes GPX4 synthesis by activating mTORC1, sensitizing cancer cells to ferroptosis. Inhibiting mTORC1 decreases GPX4 protein levels and enhances the effectiveness of ferroptosis inducers in cancer treatment.

NATURE COMMUNICATIONS (2021)

Review Oncology

Metabolic Codependencies in the Tumor Microenvironment

Prasenjit Dey et al.

Summary: Cancer cell metabolic reprogramming is driven by signals from both intrinsic and extrinsic factors. Intrinsic signaling maintains the baseline metabolic state, while extrinsic signals fine-tune metabolic processes based on metabolite availability and cellular requirements. Therefore, successful targeting of metabolic pathways will require a nuanced approach based on cancer genotype, tumor microenvironment composition, and tissue location.

CANCER DISCOVERY (2021)

Review Cell Biology

Role of Reductive versus Oxidative Stress in Tumor Progression and Anticancer Drug Resistance

Kyung-Soo Chun et al.

Summary: Redox homeostasis is crucial for normal physiological functions and plays a significant role in cancer cell growth, survival, and therapy resistance. Nrf2 is a key stress-responsive transcription factor responsible for maintaining cellular redox balance. Dysregulation of Nrf2 can lead to reductive stress, affecting the development and resistance of cancer cells.

CELLS (2021)

Article Chemistry, Multidisciplinary

Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer

Rundi Song et al.

Summary: Researchers have developed a immunotherapy method that enhances the immunogenicity of tumor cells by inducing ferroptosis, thereby improving the efficacy of cancer immunotherapy.

ADVANCED MATERIALS (2021)

Review Chemistry, Multidisciplinary

Engineering nanomedicine for glutathione depletion-augmented cancer therapy

Yuxuan Xiong et al.

Summary: The combination of nanomedicine with GSH scavenging agents and therapeutic drugs has attracted significant interest in enhancing cancer treatment outcomes. Despite unsatisfactory results, this approach has shown promising results in a large number of rodent tumor models.

CHEMICAL SOCIETY REVIEWS (2021)

Article Medicine, Research & Experimental

Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors

Qingbo Xu et al.

Summary: The manganese porphyrin-based metal-organic framework (Mn-MOF) demonstrates great potential in enhancing cancer therapy through sonodynamic therapy and ferroptosis, showing strong anticancer activity and antitumor immunity in hypoxic tumors.

THERANOSTICS (2021)

Review Pharmacology & Pharmacy

Emerging roles of F-box proteins in cancer drug resistance

Linzhi Yan et al.

DRUG RESISTANCE UPDATES (2020)

Review Biochemistry & Molecular Biology

Exosome-orchestrated hypoxic tumor microenvironment

Wanrong Meng et al.

MOLECULAR CANCER (2019)

Review Pharmacology & Pharmacy

Novel therapeutic strategy for cancer and autoimmune conditions: Modulating cell metabolism and redox capacity

Xing-Xing Fan et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Article Chemistry, Multidisciplinary

Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy

Sara Musetti et al.

ACS NANO (2018)

Review Pharmacology & Pharmacy

Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics

Ruud H. Wijdeven et al.

DRUG RESISTANCE UPDATES (2016)

Article Immunology

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

Christina Pfirschke et al.

IMMUNITY (2016)